# Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial

Study · id `cardio:ct-nct07454707` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07454707](<https://clinicaltrials.gov/study/NCT07454707>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07454707

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1204 participants.

## Technical summary

Registry record NCT07454707. Randomized; single masking; primary purpose prevention. Start 2026-11 (anticipated); primary completion 2031-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 1204 participants (planned count; ClinicalTrials.gov record NCT07454707, source copy `cardio:ctgov-nct07454707-2026-10-23`, retrieved 2026-10-26)
- Planned start: 2026-11 (anticipated) (ClinicalTrials.gov record NCT07454707, source copy `cardio:ctgov-nct07454707-2026-10-23`, retrieved 2026-10-26)
- Primary completion: 2031-12 (anticipated) (ClinicalTrials.gov record NCT07454707, source copy `cardio:ctgov-nct07454707-2026-10-23`, retrieved 2026-10-26)
- Completion: 2031-12 (anticipated) (ClinicalTrials.gov record NCT07454707, source copy `cardio:ctgov-nct07454707-2026-10-23`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT07454707, source copy `cardio:ctgov-nct07454707-2026-10-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07454707-2026-10-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial
- Acronym: STROKE75+
- Condition: Stroke, Ischemic
- Intervention (Drug): Edoxaban 15 mg
- Intervention (Drug): Aspirin or clopidogrel
- Lead sponsor: Sunnybrook Health Sciences Centre
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Sunnybrook Health Sciences Centre (`cardio:org-sunnybrook-health-sciences-centre`)

## Provenance

Content hash: eb6de9382fdcb765f65024594f94deaf3321c3076d73563b9cf9ddda2dd470c3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
